These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30549433)

  • 1. Lethal thrombocytopenia in a patient treated with avelumab for metastatic Merkel cell carcinoma.
    Kratzsch D; Simon JC; Pönitzsch I; Ziemer M
    J Dtsch Dermatol Ges; 2019 Jan; 17(1):73-75. PubMed ID: 30549433
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Avelumab (Bavencio) for metastatic merkel cell carcinoma.
    Med Lett Drugs Ther; 2017 Jul; 59(1521):e120. PubMed ID: 28699934
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial.
    Lambert J; Marrel A; D'Angelo SP; Burgess MA; Chmielowski B; Fazio N; Gambichler T; Grob JJ; Lebbé C; Robert C; Russell J; Güzel G; Bharmal M
    Patient; 2020 Aug; 13(4):457-467. PubMed ID: 32472503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avelumab for the treatment of metastatic Merkel cell carcinoma.
    Cordes LM; Gulley JL
    Drugs Today (Barc); 2017 Jul; 53(7):377-383. PubMed ID: 28837181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
    Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
    Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
    Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Merkel cell carcinoma in chronic lymphocytic leukemia : Successful treatment with PD-L 1 inhibition, avelumab and chlorambucil].
    Dücker P; Hüning S; Rohde S; Lorenzen J; Nashan D
    Hautarzt; 2020 Jul; 71(7):553-556. PubMed ID: 32394077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful rechallenge with avelumab in Merkel cell carcinoma.
    Amiot M; Brunet Possenti F; Lebbé C; Baroudjian B
    Eur J Cancer; 2021 Aug; 153():96-97. PubMed ID: 34153719
    [No Abstract]   [Full Text] [Related]  

  • 9. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
    Ascierto PA; Orlova K; Grignani G; Dudzisz-Śledź M; Fenig E; Chiarion Sileni V; Fazio N; Samimi M; Mortier L; Gebhardt C; Kramkimel N; Steven N; Bechter O; Arance A; Benincasa E; Kostkova L; Costa N; Lorigan P
    Int J Cancer; 2021 Dec; 149(11):1926-1934. PubMed ID: 34310716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.
    Heppt MV; Schlaak M; Eigentler TK; Kähler KC; Kiecker F; Loquai C; Meier F; Tomsitz D; Brenner N; Niesert AC; Thonke R; Hauschild A; Berking C
    Ann Oncol; 2017 Dec; 28(12):3104-3106. PubMed ID: 28950303
    [No Abstract]   [Full Text] [Related]  

  • 11. Avelumab: A Review in Metastatic Merkel Cell Carcinoma.
    Shirley M
    Target Oncol; 2018 Jun; 13(3):409-416. PubMed ID: 29799096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprogression of Merkel cell carcinoma after avelumab treatment.
    Pirker R; Fink A; Stella A; Stifter L; Posch C
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e675-e677. PubMed ID: 36662601
    [No Abstract]   [Full Text] [Related]  

  • 14. Unknown primary Merkel cell carcinoma responding well to first-line treatment with avelumab.
    Hanai S; Shimauchi T; Kageyama R; Aoshima M; Ito T; Tokura Y
    J Dermatol; 2019 Aug; 46(8):e273-e275. PubMed ID: 30802319
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma.
    Kaufman HL; Hunger M; Hennessy M; Schlichting M; Bharmal M
    Future Oncol; 2018 Feb; 14(3):255-266. PubMed ID: 29219612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell Carcinoma after Avelumab.
    Mendoza P; Chuang KL
    Perm J; 2021 May; 25():. PubMed ID: 33970097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
    Glutsch V; Kneitz H; Goebeler M; Gesierich A; Schilling B
    Ann Oncol; 2019 Oct; 30(10):1667-1668. PubMed ID: 31350554
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab.
    Lanitis T; Proskorovsky I; Ambavane A; Hunger M; Zheng Y; Bharmal M; Phatak H
    Adv Ther; 2019 Sep; 36(9):2327-2341. PubMed ID: 31350728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
    Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA
    Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.
    Sherry AD; Bezzerides M; Khattab MH; Luo G; Ancell KK; Kirschner AN
    Strahlenther Onkol; 2020 Jul; 196(7):664-670. PubMed ID: 32006066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.